MARKET OVERVIEW- EUROPE DRUG TESTING MARKET
To Drug screening test mainly examine biological samples like blood, hair, and urine to determine whether a patient’s body contains drugs or their metabolites, drug screening. To ascertain whether or not a person is currently or has ever been under the influence of drugs, drug screening tests are used. new technology has been introduced, giving users precise and accurate results. The increase in alcohol consumption among young and old, the excessive use of prescription drugs, the increase in the consumption of narcotics and illicit drugs are some of the key an important driver for the market. In order to decrease the consumption of addictive drugs, strict regulations are widely imposed all over the world. Due to these factors, the market is expected to grow tremendously over the forecast period.
MARKET DRIVERS
The increasing supportive regulations and mandates are expected to boost the growth of the European drug testing market in the upcoming years. For example, workplace drug testing is legal in the UK. The growing incidence of substance abuse across the region has led to an increase in the need for its screening, which has propelled the demand for drug testing. Additionally, the screening is simple to put into practice, providing flexible and successful workplace drug testing, which is also expected to support market growth. Moreover, the rise in government spending to combat drug trafficking is anticipated to drive the market.
MARKET RESTRAINTS
The right to privacy and bans on alcohol in various countries is further projected to impede the growth of the Europe Drug testing market in the timeline period. For instance, many European countries impose fine for unjustified testing, with criminal penalties. This is considered an invasion of employee privacy. Therefore, such strict privacy rights are likely to limit the drug testing market’s growth.
MARKET GROWTH CHALLENGES
A key challenge that may affect the growth of the market is the lack of skilled workers in the healthcare sector in underdeveloped nations is expected to be major challenge for the market growth over the forecast period. Also, the ban on the consumption of drugs in certain places and the lack of healthcare infrastructure in developing countries are expected to hamper the growth of the Europe drug testing market during the forecast period.
CUMULATIVE GROWTH ANALYSIS
The report provides in-depth analysis of the Europe drug testing market, market size, and compound annual growth rate (CAGR) for the forecast period of 2023-2029, considering 2022 as the base year. The increasing demand for various Drug Testing Services in various substance and drug abuse applications has led to an increase in market demand and is expected to witness the growth at a specific CAGR from 2023-2029.
EUROPE DRUG TESTING MARKET SEGMENTAL OVERVIEW
The Europe drug testing market comprises of different market segment like products and services, sample type, drug type, end-users, and country.
EUROPE DRUG TESTING MARKET BY PRODUCTS AND SERVICES
By products and services, the Drug Testing Market includes the key segment of
- Consumables
- Instruments
- Rapid Testing Devices
- Laboratory Services
The consumables segment is anticipated to dominate the market over the projected time period. The increasing introduction of advanced consumables that provide improved solutions to make testing, simple, accurate, and fast expected to accelerate market growth. For instance, in August 2019, MedTest Dx, Inc. introduced Clinitox Calibrators and Controls at the 2019 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting. These calibrators and controls perform confirmation testing for laboratories to eliminate measurement of steps and manage controls and certifications, need to acquire and set-up materials, and multiple handling.
Furthermore, the laboratory services segment is expected to witness high growth over the forecast period. An increase in strategic initiative being undertaken by various companies such as acquisitions, collaborations, and partnerships to support public safety and government agencies has propelled the segmental growth.
EUROPE DRUG TESTING MARKET BY SAMPLE TYPE
By sample type, the Drug Testing Market includes the key segment of
- Urine
- Breath
- Oral Fluid
- Hair
The urine sample segment is anticipated to dominate the market over the projected time period. This rapid growth can be attributed to the fact that urine sample are the most frequent sample type used to test for the presence of illicit drugs. To produce a false-negative test result, adulteration is now a common occurrence in urine samples, which can be a negative effect on market expansion.
Further, the oral fluid segment is expected to witness high growth over the forecast period. It is a quicker and less invasive sample to collect at the roadside. Oral fluid samples are preferred over urine samples due to their ability to save time and preserve dignity, regardless of the additional costs, according to the NCBI 2020 study, which was based on a survey of both staff and patients.
EUROPE DRUG TESTING MARKET BY DRUG TYPE
By drug type, the Drug Testing Market includes the key segment of
- Alcohol
- Cocaine
- Opioids,
- Amphetamine and Methamphetamine
- Cannabis/Marijuana
- LSD
The cannabis/ Marijuana segment is anticipated to dominate the market over the projected time period. Cannabis/marijuana, is the most widely used illicit substance in important markets, and as a result, testing kits and equipment are in high demand.
The opioids segment is expected to witness high growth over the forecast period. The introduction of innovative opioids testing solutions is expected to boost demand growth. In July 2017, Alere Inc., a subdiary of Abbott Laboratories, launched the Alere icup Rx Drug Screen. This rapid point-of-care urine test developed for the detection of the most commonly abused prescription medications such as buprenorphine, benzodiazepines, opiates, methadone, and oxycodone.
EUROPE DRUG TESTING MARKET BY END-USER
By end-user, the Drug Testing Market includes the key segment of
- Drug Testing Laboratories
- Workplaces
- Hospitals
- Drug Treatment Centers
- Individual Users
- Criminal Justice Systems and Law Enforcement Agencies
- Pain Management Centers
- Pain Management Centers
The drug testing laboratories segment is anticipated to dominate the market over the projected time period. Drug testing laboratories can detect the presence of nay illicit substance. The accessibility of high-tech tools like HPLC and spectroscopy, as well as the availability of trained personnel for testing in order to produce accurate results, are additional benefits of drug testing laboratories. In comparison to rapid tests, laboratories therefore provide test results with greater sensitivity and specificity.
EUROPE DRUG TESTING MARKET BY COUNTRY
The Europe Drug Testing market is studied for the following countries
- United Kingdom
- Germany
- France
- Italy
- Spain
- Rest of Europe
The United Kingdom is projected to lead the market during the forecast period. The increasing approval for new drug abuse screening devices along with funding to develop new devices is anticipated to propel the growth of the market in this region. The presence of significant players undertaking comprehensive growth strategies and supportive reimbursement policies will further fuel the growth of the testing market over the forecast period.
COMPETITIVE LANDSCAPE ANALYSIS
The competitive landscape analysis of Drug Testing Market is majority focused on expanding the growth of drug testing through new product innovation, business expansion, and the increasing presence of key players operating in Drug Testing industry has led to the growing demand for the market. Besides, the market offers range of testing services in different applications to fulfil the required demand of consumers, which further contributes healthy growth in the market.
The key players studied in market are
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- Biorad Laboratories, Inc.
- Siemens AG
- Hoffmann-La Roche AG
- Quidel Corporation
- Agilent Technologies, Inc.
- Quest Diagnostics Incorporated
- Shimadzu
- LabCorp
- American Bio Medica Corporation
- CareHealth America Corp
- Omega Laboratories, Inc.
- LifeLoc Technologies
- Premier Biotech, Inc.
- Clinical Reference Laboratory
- Cordant Health Solutions
RECENT DEVELOPMENT:
AUGUST 2017: - Intelligent Fingerprinting Limited, an U.K. based company launched world’s first portable fingerprint drug test for detection and analysis of cocaine, opiates, Cannabis and amphetamines. The newly launched device enabled collection and analysis of sample in just 10 minutes making the process quicker.
